Robert C. Castellino

2.1k total citations
49 papers, 1.2k citations indexed

About

Robert C. Castellino is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Robert C. Castellino has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Genetics and 14 papers in Neurology. Recurrent topics in Robert C. Castellino's work include Glioma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (11 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Robert C. Castellino is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (11 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Robert C. Castellino collaborates with scholars based in United States, Canada and Germany. Robert C. Castellino's co-authors include Randall L. Rasmusson, Harold C. Strauss, Michael J. Morales, Donald L. Durden, Tobey J. MacDonald, Dolly Aguilera, Rita Nahta, Anne L. Crews, John Y.H. Kim and Massimiliano De Bortoli and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Physiology.

In The Last Decade

Robert C. Castellino

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Castellino United States 21 901 306 253 241 193 49 1.2k
Michael G. Poulos United States 24 1.5k 1.6× 298 1.0× 170 0.7× 178 0.7× 462 2.4× 32 2.3k
Daniel Sherman United States 10 1.1k 1.2× 125 0.4× 252 1.0× 170 0.7× 237 1.2× 13 1.6k
Ivo F.A.C. Fokkema Netherlands 12 1.6k 1.8× 300 1.0× 82 0.3× 307 1.3× 141 0.7× 18 2.1k
Sean C. Goetsch United States 18 1.3k 1.5× 202 0.7× 163 0.6× 434 1.8× 75 0.4× 22 1.8k
Aurelio Hernández‐Laín Spain 19 456 0.5× 572 1.9× 201 0.8× 58 0.2× 74 0.4× 88 1.3k
Donald A. Bergstrom United States 18 1.6k 1.8× 273 0.9× 402 1.6× 50 0.2× 104 0.5× 44 2.2k
Hanna M. Eilken Germany 11 1.2k 1.4× 98 0.3× 159 0.6× 76 0.3× 177 0.9× 13 1.9k
Claudia Prahst United States 16 1.1k 1.2× 113 0.4× 338 1.3× 62 0.3× 438 2.3× 17 1.6k
Marco Gymnopoulos United States 13 835 0.9× 180 0.6× 262 1.0× 76 0.3× 158 0.8× 16 1.2k
Caroline G. Humphries United States 13 1.2k 1.3× 203 0.7× 148 0.6× 169 0.7× 120 0.6× 17 1.7k

Countries citing papers authored by Robert C. Castellino

Since Specialization
Citations

This map shows the geographic impact of Robert C. Castellino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Castellino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Castellino more than expected).

Fields of papers citing papers by Robert C. Castellino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Castellino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Castellino. The network helps show where Robert C. Castellino may publish in the future.

Co-authorship network of co-authors of Robert C. Castellino

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Castellino. A scholar is included among the top collaborators of Robert C. Castellino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Castellino. Robert C. Castellino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castellino, Robert C., Hope Mumme, Andrea Franson, et al.. (2025). First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients. JCI Insight. 11(3).
2.
Reddy, Karla Mahender, Eswar Damaraju, Zuping He, et al.. (2025). BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience. Frontiers in Oncology. 14. 1505951–1505951.
3.
Cohen, Kenneth J., Dolly Aguilera, Robert C. Castellino, et al.. (2023). A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. Clinical Cancer Research. 29(24). 5031–5037. 9 indexed citations
4.
Rota, Christopher, Alexander Brown, Kristine Pelton, et al.. (2022). Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas. Neuro-Oncology Advances. 4(1). vdac049–vdac049. 3 indexed citations
5.
Summers, Ryan J., Sharon M. Castellino, Christopher C. Porter, et al.. (2022). Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care. JCO Precision Oncology. 6(6). e2100451–e2100451. 8 indexed citations
6.
Cohen, Kenneth J., Susan Chi, Cynthia Hawkins, et al.. (2020). MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES. Neuro-Oncology. 22(Supplement_3). iii393–iii394. 3 indexed citations
7.
Nahta, Rita & Robert C. Castellino. (2020). Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer. Biochemical Pharmacology. 184. 114362–114362. 11 indexed citations
8.
Cash, Thomas F., Dolly Aguilera, Margaret E. Macy, et al.. (2019). Abstract C002: Phase 1 study of abemaciclib in children with recurrent and refractory solid tumors including malignant brain tumors. Molecular Cancer Therapeutics. 18(12_Supplement). C002–C002.
9.
Wen, Jinhua, Jaewon J. Lee, Anshu Malhotra, et al.. (2016). WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma. Oncogene. 35(42). 5552–5564. 19 indexed citations
10.
Aguilera, Dolly, Anna J. Janss, Claire Mazewski, et al.. (2015). Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib. Pediatric Blood & Cancer. 63(3). 541–543. 40 indexed citations
12.
MacDonald, Tobey J., Dolly Aguilera, & Robert C. Castellino. (2013). The rationale for targeted therapies in medulloblastoma. Neuro-Oncology. 16(1). 9–20. 49 indexed citations
13.
Aguilera, Dolly, Robert Flamini, Claire Mazewski, et al.. (2013). Response of Subependymal Giant Cell Astrocytoma With Spinal Cord Metastasis to Everolimus. Journal of Pediatric Hematology/Oncology. 36(7). e448–e451. 9 indexed citations
14.
Abouantoun, Thamara J., Robert C. Castellino, & Tobey J. MacDonald. (2010). Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells. Journal of Neuro-Oncology. 101(2). 215–226. 44 indexed citations
15.
Castellino, Robert C., Massimiliano De Bortoli, Darlene G. Skapura, et al.. (2007). Overexpressed TP73 induces apoptosis in medulloblastoma. BMC Cancer. 7(1). 127–127. 38 indexed citations
16.
Castellino, Robert C., Massimiliano De Bortoli, Xiongbin Lu, et al.. (2007). Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. Journal of Neuro-Oncology. 86(3). 245–256. 108 indexed citations
17.
Bortoli, Massimiliano De, Robert C. Castellino, Adekunle M. Adesina, et al.. (2006). Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. BMC Cancer. 6(1). 223–223. 62 indexed citations
18.
Cowan, Christopher W., et al.. (2005). A Novel Role for Extracellular Signal-Regulated Kinase 5 and Myocyte Enhancer Factor 2 in Medulloblastoma Cell Death. Cancer Research. 65(13). 5683–5689. 29 indexed citations
19.
Friedman, Henry S., Robert C. Castellino, Gertrude B. Elion, et al.. (2000). Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts. Cancer Chemotherapy and Pharmacology. 45(4). 345–349. 30 indexed citations
20.
Castellino, Robert C., et al.. (1992). AERODYNAMIC FORCES ON MAGLEV VEHICLES. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026